Literature DB >> 9924061

Science, medicine, and the future: Parkinson's disease.

A H Schapira1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9924061      PMCID： PMC1114782          DOI： 10.1136/bmj.318.7179.311

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.

Authors:  T A Seaton; J M Cooper; A H Schapira
Journal:  Brain Res       Date:  1997-11-28       Impact factor: 3.252

3.  Welcome news about levodopa, but uncertainty remains.

Authors:  S Fahn
Journal:  Ann Neurol       Date:  1998-05       Impact factor: 10.422

Review 4.  Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis.

Authors:  N Zamzami; T Hirsch; B Dallaporta; P X Petit; G Kroemer
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 5.  Fetal nigral transplantation as a therapy for Parkinson's disease.

Authors:  C W Olanow; J H Kordower; T B Freeman
Journal:  Trends Neurosci       Date:  1996-03       Impact factor: 13.837

6.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

7.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

8.  L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro.

Authors:  C Mytilineou; P M Radcliffe; C W Olanow
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

9.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

Authors:  T Gasser; B Müller-Myhsok; Z K Wszolek; R Oehlmann; D B Calne; V Bonifati; B Bereznai; E Fabrizio; P Vieregge; R D Horstmann
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

10.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

Authors: 
Journal:  N Engl J Med       Date:  1993-01-21       Impact factor: 91.245
View more
  35 in total

1.  Medical management of Parkinson's disease.

Authors:  C E Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  The relative health related quality of life of veterans with Parkinson's disease.

Authors:  H Gage; A Hendricks; S Zhang; L Kazis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 3.  Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.

Authors:  Anthony H V Schapira
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

4.  Reprogrammed astrocytes with old 'memories' blossom into region-specific neurons.

Authors:  Anuja Ghorpade
Journal:  Protein Cell       Date:  2011-02       Impact factor: 14.870

Review 5.  Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis.

Authors:  Richard L Jayaraj; Eric A Rodriguez; Yi Wang; Michelle L Block
Journal:  Curr Environ Health Rep       Date:  2017-06

6.  Neuroprotective effects of bikaverin on H2O2-induced oxidative stress mediated neuronal damage in SH-SY5Y cell line.

Authors:  D Nirmaladevi; M Venkataramana; S Chandranayaka; A Ramesha; N M Jameel; C Srinivas
Journal:  Cell Mol Neurobiol       Date:  2014-05-22       Impact factor: 5.046

Review 7.  Aetiopathogenesis of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

8.  Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease.

Authors:  Bong-Suk Choi; Hyool Kim; Hyo Jeong Lee; Kumar Sapkota; Se Eun Park; Seung Kim; Sung-Jun Kim
Journal:  Neurochem Res       Date:  2013-11-09       Impact factor: 3.996

9.  Rutin from Dendropanax morbifera Leveille protects human dopaminergic cells against rotenone induced cell injury through inhibiting JNK and p38 MAPK signaling.

Authors:  Se-Eun Park; Kumar Sapkota; Jun-Hui Choi; Myung-Kon Kim; Young Hoi Kim; Ki Man Kim; Kyung Je Kim; Ha-Na Oh; Sung-Jun Kim; Seung Kim
Journal:  Neurochem Res       Date:  2014-02-19       Impact factor: 3.996

10.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.